Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse
CompletedNot applicableNCT02423772
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic pain and misuse of opioids is a major public health problem, particularly in military veterans. The major goal of this project is to test the efficacy of an innovative behavioral treatment for chronic pain patients who are misusing prescription opiates. This project supports the strategic goals of National Center for Complementary and Integrative Health (NCCIH) and National Institute on Drug Abuse by examining a difficult and understudied problem with the ultimate goal of impacting scientific knowledge and human health.
Study details
- Official title
- Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse
- Conditions
- Chronic Pain
- Problematic Opioid Use
- Interventions
- Behavioral: Acceptance and Commitment Therapy + Mindfulness-Based Relapse Prevention + Treatment as Usual (TAU)
- Sponsor
- University of New Mexico
- Start date
- 2014-08
- Primary completion
- 2018-07
- Sex
- All
- Age range
- from 21 Years to 65 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Aged 21-65 years old * Diagnosis of chronic pain condition * Pain severity over the past seven days of four or greater on a 0-10 scale * Prescribed opioids for the treatment of chronic pain for the past 90 days or longer * Ability to read written English Exclusion Criteria: * Meet diagnostic criteria for current substance abuse/dependence on a drug other than opioids * Meet diagnostic criteria for a current or past DSM diagnosis of schizophrenia, delusional disorder, psychotic or dissociative disorders, * Currently prescribed medications for opioid addiction (e.g., Buprenorphine/Naloxone/Suboxone). * History of suicide attempts or inpatient hospitalization for risk of suicide in the past six month. In addition, we will screen for significant suicidal
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02423772